Addus HomeCare (NASDAQ:ADUS) Downgraded by Barclays

Addus HomeCare (NASDAQ:ADUS) was downgraded by equities researchers at Barclays from an “equal weight” rating to an “underweight” rating in a report released on Tuesday, MarketBeat Ratings reports. They currently have a $83.00 target price on the stock. Barclays‘s price objective points to a potential downside of 11.22% from the company’s previous close.

Several other equities analysts have also commented on ADUS. Royal Bank of Canada reiterated an “outperform” rating and set a $102.00 price objective on shares of Addus HomeCare in a research report on Thursday, February 29th. William Blair restated an “outperform” rating on shares of Addus HomeCare in a report on Monday, February 5th. Finally, Oppenheimer restated an “outperform” rating and set a $118.00 target price on shares of Addus HomeCare in a report on Tuesday, March 26th. One equities research analyst has rated the stock with a sell rating and seven have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $103.00.

Addus HomeCare Stock Down 3.8 %

Shares of NASDAQ ADUS opened at $93.49 on Tuesday. Addus HomeCare has a one year low of $77.30 and a one year high of $114.97. The company has a debt-to-equity ratio of 0.18, a current ratio of 1.38 and a quick ratio of 1.38. The business’s fifty day moving average price is $97.58 and its 200-day moving average price is $91.48. The stock has a market capitalization of $1.52 billion, a PE ratio of 24.35, a P/E/G ratio of 1.92 and a beta of 0.95.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings results on Monday, February 26th. The company reported $1.21 EPS for the quarter, beating analysts’ consensus estimates of $1.04 by $0.17. Addus HomeCare had a return on equity of 9.70% and a net margin of 5.91%. The firm had revenue of $276.35 million for the quarter, compared to analysts’ expectations of $274.02 million. On average, equities research analysts anticipate that Addus HomeCare will post 4.38 EPS for the current year.

Hedge Funds Weigh In On Addus HomeCare

Several institutional investors and hedge funds have recently bought and sold shares of ADUS. Exchange Traded Concepts LLC lifted its position in shares of Addus HomeCare by 0.8% in the fourth quarter. Exchange Traded Concepts LLC now owns 14,310 shares of the company’s stock valued at $1,329,000 after acquiring an additional 113 shares in the last quarter. Guinness Asset Management LTD increased its stake in Addus HomeCare by 2.7% during the third quarter. Guinness Asset Management LTD now owns 5,267 shares of the company’s stock worth $449,000 after acquiring an additional 137 shares during the last quarter. GAMMA Investing LLC increased its stake in Addus HomeCare by 40.8% during the first quarter. GAMMA Investing LLC now owns 556 shares of the company’s stock worth $57,000 after acquiring an additional 161 shares during the last quarter. Sheets Smith Wealth Management increased its stake in Addus HomeCare by 2.5% during the third quarter. Sheets Smith Wealth Management now owns 6,892 shares of the company’s stock worth $587,000 after acquiring an additional 168 shares during the last quarter. Finally, Assetmark Inc. increased its stake in Addus HomeCare by 17.1% during the third quarter. Assetmark Inc. now owns 1,331 shares of the company’s stock worth $113,000 after acquiring an additional 194 shares during the last quarter. 95.35% of the stock is currently owned by hedge funds and other institutional investors.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.